EoPancreas: New Diabetes Patch Pump and CGM System in Development

FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.

Insulet, Abbott earn EU nod for artificial pancreas system

Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)

Quarterly Update Diabetes Technology

Diabetes Café (@Diabetesto) / X

Quarterly Update Diabetes Technology

Artificial Pancreas Improves Glycemic Control in Young Kids With T1D

Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems

Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App

Omnipod CGM and Pump Patch - Diabetes UK Shop

Artificial Pancreas aka Automated Insulin Delivery: What You Should

Diabetes Insulin Pumps & Patches: What Are They

Quarterly Update Diabetes Technology

Artificial Pancreas aka Automated Insulin Delivery: What You Should